目前正在实施的研究策略是使用针对细胞因子的单克隆抗体。尽管抗TNF疗法已成功地用于类风湿关节炎的治疗,但阻断EIU期间全身的TNF则使病情恶化[32]。其他的策略还包括:(1)使用“反义寡核苷酸”阻断RNA的转录在基因水平上调控细胞因子网络;(2)抑制参与某些细胞因子分泌的酶类(如金属蛋白酶);(3)通过定向基因疗法将某些基因导入眼组织使其发生短暂性表达增强。然而,应该认识到的是,许多细胞因子对于网络稳态的维持可能起着重要的作用,打破这个复杂的网络将可能得到与预想相矛盾的结果。
基金项目:国家自然科学基金(No.39970250)、教育部霍英东教育基金会资助(No.91039)
作者单位:李志杰(510632 广州市,暨南大学组织移植与免疫中心眼科学教研室)
彭广华(510632 广州市,暨南大学组织移植与免疫中心眼科学教研室)
参考文献
1,Abbas AK, Lightman AH, pober JS. Cellular and Molecular Immunology. 3rd ed. Philadelphia∶ WB Saunders company[M]. 1997∶249-277.
2,李志杰,彭广华. 眼的免疫调控机制[J]. 眼科新进展 2000;20(1)∶1-4.
3,Holtkamp GM, de Vos AF, Kijlstra A, et al. Expression of multiple forms of iL-1 receptor antagonist (IL-1ra) by human retinal pigment epithelial cells∶ identification of a new IL-1ra exon[J]. Eur J Immunol 1999; 29∶215-224.
4,Kuppner MC, MeKillop-Smith S, Forrester JV. TGF-β and IL-l act in synergy to enhance IL-6 and IL-8 mRNA levels and IL-6 production by human retinal pigment epithelial cells[J]. Immunology 1995; 84∶265-271.
5,Lang RA, Metcalf D, Cuthbertson RA, et al. Transgenic mice expressing a hemopoietic growth factor gene (GM-CSF) develop accumulations of macrophages, blindness, and a fatal syndrome of tissue damage[J]. Cell 1987;51∶675-686.
6,Dvorak AM, Tepper RI, Weller PF, et al. Piecemeal degranulation of mast cells in the inflammatory eyelid lesions of interleukin-4 transgenic mice∶ evidence of mast cell histamine release in vivo by diamine oxidase-gold enzyme-affinity ultrastructural cytochemistry[J]. Blood 1994;83∶3600-3612.
7,Geiger K, Howes E, Gallina M, et al. Transgenic mice expressing IFN-gamma in the retina develop inflammation of the eye and photoreceptor loss[J]. Invest ophthalmol Vis Sci 1994; 35∶2667-2681.
8,Geiger K, Howes EL, Sarvetnick N. Ectopic expression of gamma interferon in the eye protects transgenic mice from intraocular herpes simplex virus type 1 infections[J]. J Virol 1994; 68∶5556-5567.
9,Egwuagu CE, Sztein J, Chan CC, et al. Ectopic expression of gamma interferon in the eyes of transgenic mice induces ocular pathology and MHC class II gene expression[J]. Invest Ophthalmol Vis Sci 1994; 35∶332-341.
10,Jones LS, Rizzo LV, Agarwal R, et al. Interferon gamma (IFN-γ) deficient mice are susceptible to induction of experimental autoimmune uveitis (EAU)[J]. invest Ophthalmol Vis Sci 1996; 37∶S5896.
11,Rosenbaum JT, Kievit P, Han YB, et al. Interleukin-6 dose not mediate endotoxin-induced uveitis in mice∶ studies in gene deletion animals[J]. invest Ophthalmol Vis Sci 1999; 39∶64-69.
12,Murray PI, Hoekzema R, van Haren MAC, et al. Aqueous humor interleukin-6 levels in uveitis[J]. Invest Ophthalmol Vis Sci 1990; 31∶917-920.
13,de Boer JH, van Haren MAC, de Vries-Knoppert WAEJ, et al. Analysis of IL-6 levels in human vitreous fluid obtained from uveitis patients, patients with proliferative intraocular disorders and eye bank eyes[J]. Curr Eye Res 1992;11∶181-186.
14,de Boer JH, Hack CE, Verhoeven AJ, et al. Chemoattractant and neutrophil degranulation activities related to interleukin-8 in vitreous fluid in uveitis and vitreoretinal disorders[J]. Invest Ophthalmol Vis Sci 1993;34∶3376-3385.
15,Mondino BJ, Sidikaro Y, Mayer FJ, et al. Inflammatory mediators in the vitreous humor of AIDS patients with retinitis[J]. Invest Ophthalmol Vis Sci1990; 30∶798-804.
16,el-Shabrawi Y, Livir-Rallatos C, Christen W, et al. High levels of interleukin-12 in the aqueous humor and vitreous of patients with uveitis[J]. ophthalmology 1998; 105∶1659-1663.
17,Nishi O, Nishi K, Imanishi M. Synthesis of interleukin-1 and prostaglandin e2 by lens epithelial cells of human cataracts[J]. Br J Ophthalmol 1992;76∶338-341.
18,Whitcup SM, Stark-Vancs V, Wittes RE, et al. Association of interleukin 10 in the vitreous and cerebrospinal fluid and primary central nervous system lymphoma[J]. Arch Ophthalmol 1997; 115∶1157-1160.
19,Chan CC, Scott M, Whitcup MD, et al. Interleukin-l0 in the vitreous of patients with primary intraocular lymphoma[J]. Am J Ophthalmol 1995;120∶671-673.
20,el-Shabrawi Y, Livir-Rallatos C, Christen W, et al. High levels of interleukin-12 in the aqueous humor and vitreous of patients with uveitis[J]. ophthalmology 1998; 105∶1659-1663.
21,de Boer JH, Limpens J, Orengo-Nania S, et al. Low mature TGF-β2 levels in aqueous humor[J]. Invest Ophthalmol Vis Sci 1994; 35∶3702-3710.
22,Schultz MW, Chamberlain CG, McAvoy JW. Inhibition transforming growth factor-β-induced cataractous changes in lens explants by ocular media and α2-macroglobulin[J]. invest Ophthalmol Vis Sci 1996; 37∶ 1509-1519.
23,Limb GA, Chignell AH, Green W, et al. Distribution of TNF-alpha and its reactive vascular adhesion molecules in fibrovascular membranes of proliferative diabetic retinopathy[J]. BrJ Ophthalmol 1996; 80∶168-173.
24,Nishi O, Nishi K, Obmoto Y. Effect of interleukin-1 receptor antagonist on the blood-aqueous barrier after intraocular lens implantation[J]. Br J ophthalmol 1994; 78∶917-920.
25,Rosenbaum JT, Angell E. Paradoxical effects of IL-10 in endotoxin-induced uveitis[J]. J Immunol 1995; 155∶4090-4094.
26,Hayashi S, Guex-Crosier Y, Delvaux A, et al. Interleukin-10 inhibits inflammatory cell infiltration in endotoxin-induced uveitis[J]. Graefes Arch clin Exp Ophthalmol 1996; 234∶633-636.
27,Ramanathan S, de Kozak Y, Saoudi A, et al. Recombinant IL-4 aggravates experimental autoimmune uveoretitis in rats[J]. J Immunol 1996;157∶2209-2215.
28,Whitcup SM, Rizzo LV, Lai JC, et al. IL-12 inhibits endotoxin-induced inflammation in the eye[J]. Eur J Immunol 1996;26∶995-999.
29,Roberge FG, de Smet MD, Benichou J, et al. Treatment of uveitis with recombinant human interleukin-13[J]. Br J Ophthalmol 1998; 82∶1195-1198
30,Okada AA, Keino H, Fukai T, et al. Effect of type I interferon on experimental autoimmune uveoretinitis in rats[J]. Ocular Immunol Inflamm1998; 6∶215-226.
31,Okada AA, Keino H, Suzuki J, et al. Kinetics of intraocular cytokines in the suppression of experimental autoimmune uveoretinitis by type I IFN[J]. int Immunol 1998; 10∶1712-1722.
32,de Vos AF, van Haren MAC, Verhagen C, et al. Systemic anti-tumor necrosis factor antibody treatment exacerbates endotoxin-induced uveitis in the rat[J]. exp Eye Res 1995; 61∶667-675.
上一页 [1] [2] |